A detailed history of Silverlake Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Silverlake Wealth Management LLC holds 9,878 shares of ABBV stock, worth $1.78 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
9,878
Previous 9,792 0.88%
Holding current value
$1.78 Million
Previous $1.68 Billion 16.15%
% of portfolio
0.74%
Previous 0.69%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$163.84 - $199.33 $14,090 - $17,142
86 Added 0.88%
9,878 $1.95 Billion
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $24,456 - $28,560
158 Added 1.64%
9,792 $1.68 Billion
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $23,653 - $26,950
-148 Reduced 1.51%
9,634 $1.75 Billion
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $90,540 - $101,970
-658 Reduced 6.3%
9,782 $1.52 Billion
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $23,244 - $26,909
174 Added 1.69%
10,440 $1.56 Billion
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $6,227 - $7,750
47 Added 0.46%
10,266 $1.38 Billion
Q1 2023

Apr 12, 2023

SELL
$144.61 - $166.54 $36,152 - $41,635
-250 Reduced 2.39%
10,219 $1.63 Billion
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $1.45 Million - $1.74 Million
10,469 New
10,469 $1.69 Billion
Q3 2022

Apr 06, 2023

BUY
$134.21 - $153.93 $40,263 - $46,179
300 Added 2.93%
10,534 $1.41 Billion
Q2 2022

Apr 06, 2023

SELL
$137.62 - $174.96 $32,340 - $41,115
-235 Reduced 2.24%
10,234 $1.57 Billion
Q1 2022

Apr 06, 2023

SELL
$131.98 - $163.75 $25,736 - $31,931
-195 Reduced 1.91%
9,992 $1.62 Billion
Q4 2021

Apr 06, 2023

SELL
$107.43 - $135.93 $30,295 - $38,332
-282 Reduced 2.69%
10,187 $1.38 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Silverlake Wealth Management LLC Portfolio

Follow Silverlake Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverlake Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverlake Wealth Management LLC with notifications on news.